Resources

Presentation from Dr Sharon Lambert, School of Applied Psychology, UCC exploring the assessment and impact of Adverse Childhood Experiences with the PSI Early Graduate Group.

Dr Hannah Carver (University of Stirling) presents research on Managed Alcohol Programmes: "Investigating the need for alcohol harm reduction and Managed Alcohol Programmes for people experiencing homelessness and alcohol use disorders in Scotland".
 

Watch the video of the research presentation “Exploring men’s alcohol consumption in the context of becoming a father: A scoping review”, by Dr Elena Dimova.

Dr Andrea Mohan (University of Dundee) presented: "What can we learn from the perspectives of repeat drink-drivers? Findings from a qualitative study".
 

The Vienna NGO Committee on Drugs (VNGOC) together with the UNODC Civil Society Unit (CSU) held a webinar on 10th March 2021 discussing the International Standards on Drug Use Prevention.

Presenters Michal Miovsky and Anna Volfova discuss their implementation of learning outcomes in their addiction education program at Charles University in Prague.

The focus of this seminar is on prescription smoking cessation pharmacotherapies, which include nicotine replacement therapy patches, varenicline and bupropion.

Dr Alys Havard presents data on the number of Australian women who use these medicines during pregnancy, and their findings regarding the risk of adverse birth outcomes associated with the use of each of these medicines during pregnancy.

This presentation explored some of the alternative treatments for smoking cessation.

The National Institute on Drug Abuse (NIDA) has set up a topic page that includes DrugFact sheets, research reports and infographics on Substance use among women.

Here you can find videos, policy briefings and an extensive resource list that examines issues related to substance use among women.

Drug and Alcohol Findings bridges the divide between research on the effectiveness of responses to drug and alcohol problems and the practitioners who provide those interventions.

EMCDDA has developed a variety of resources on women and drug use including publications, data, news, events and reports.

William Miller and Stephen Rollnick, co-founders of Motivational Interviewing engage with clinicians and researchers from across Africa, drawing on lessons from existing research and dissemination activities, and exploring the broader potential of Motivational Interviewing on the African Continent.

In the webinar on 23rd February 2021 the VNGOC Asia-Pacific ad-hoc Working Group kick-started the discussions on a possible Asia-Pacific Civl Society Common Position. More than 70 people from the region participated. 

You can access the presentation here.

Why don't they just stop using drugs then? Making the case for trauma and ACE informed substance use services.

Andrew has developed trauma and ACE informed approaches in North Wales and other parts of the UK and Ireland during the last five years. From 2018 to 2020, he supported the National ACE Approach to Policing Vulnerability Programme in Wales. 

In ISAM-NIG's new monthly talk series "In-Love with Addicted Brains”, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field.

The Drugs Wheel can be used as a training tool and as a game for use in training or 1:1 sess­ions. There are free ver­sions of each to download on this site, as well as a range of other resources. When using the Drugs Wheel, please bear in mind the following: 

The SAMRC Alcohol, Tobacco & Other Drug Research Unit is now in its 20th year of existence. With about 20+ core staff based in Cape Town and Pretoria the focus is on a broad range of research focusing on the nature and extent of substance use in South Africa, associated consequences and the multifaced interventions aimed at addressing substance use.

Objective: To explore innovative programmes providing solutions in the field of homelessness and drugs.